8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 9, 2023 · 3y ago · Accession 0001193125-23-004214
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Jan 9, 2023
- Report date
- Jan 9, 2023
- Document
- d412017d8k.htm
- Size
- 7.6 MB